NDC 0143-9240
Bleomycin 15 [USP'U] injection, powder, lyophilized, for solution
On the label: Hikma Pharmaceuticals USA Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Hikma Pharmaceuticals USA Inc. names for other drugs.
Recalls
- Aug 5, 2021 · Class III · Hikma Pharmaceuticals USA Inc.
Labeling: Not elsewhere classified: Mislabeling
Lots: BL0018
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bleomycin: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intramuscular; intrapleural; intravenous; subcutaneous
- Strength
- 15 [USP'U]
- Approval
- ANDA ANDA065042
- On the market since
- Jan 9, 2018
- Package NDCs
0143-9240-01- Official label
- DailyMed (National Library of Medicine), updated Apr 11, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?